Home › Trial NCT06304636
Descartes-15 for Patients With Relapsed/Refractory Multiple Myeloma
- Trial IDNCT06304636
- StatusTerminated
- PhasePhase 1
- Study typeInterventional
- SponsorCartesian Therapeutics
- Enrollment4
- Start date2024-06-19
- ConditionsRefractory Multiple Myeloma · Relapsed Multiple Myeloma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.